Compass Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Compass Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Compass Therapeutics Inc
Rating: 1.99725
Author: Trendlyne DVM scores

about

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its...

4.83 0.06 (1.26%)

New 52W High in past week

1.5M

XNAS Volume

XNAS 14 Nov, 2025 4:30 PM (EST)

Board Meeting

The next board meeting for Compass Therapeutics Inc is on 20 Nov 2025 for the purpose of Jefferies Global Healthcare Conference See details

Not Eligible

Expensive Valuation

3.0 / 100

Technically Bullish

76.9 / 100

1Yr Price target upside is 164%

11 analysts

Compass Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Compass Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its...

New 52W High in past week

SWOT Analysis

Compass Therapeutics Inc Live Price Chart